Cera Occluders

Ceramic-Coated Occluder Systems for ASD, VSD, PDA, and PFO Closure Procedures

Lifetech Scientific developed the Cera Series as an advanced family of transcatheter closure devices for congenital and structural heart defect interventions. Designed for ASD, VSD, PDA, and PFO closure procedures, the Cera Series stands out through its versatile clinical applicability, enhanced biocompatibility strategy, and proprietary ceramic-coated device technology.

One of the most important features of the Cera Series is its specialized ceramic-coated nitinol structure. Instead of using a conventional bare-metal nitinol surface, Lifetech Scientific utilizes a titanium nitride-based ceramic coating technology designed to improve implant surface performance and enhance long-term biocompatibility.

A major advantage of this ceramic coating technology is its potential contribution to reducing ion release from the implant surface. Particularly in relation to nickel exposure considerations, this coating approach represents an important innovation supporting implant biocompatibility. The smoother implant surface is also designed to support improved endothelialization following implantation.

Another key strength of the Cera Series is its highly versatile product portfolio. The platform includes dedicated systems for ASD, VSD, PDA, and PFO closure procedures, allowing clinicians to manage multiple structural heart defect types using devices with similar operational principles and deployment workflows.

The Cera ASD Occluder systems are specifically developed for percutaneous closure of secundum atrial septal defects. Their dual-disc symmetrical architecture and flexible nitinol mesh technology support stable adaptation to varying septal anatomies while controlled deployment mechanisms enhance procedural safety.

Cera PFO Occluder systems are optimized for patent foramen ovale closure procedures. Their low-profile structure and soft disc design help improve septal conformity while supporting safe and controlled implantation.

For ventricular septal defect treatment, the Cera VSD Occluder systems are designed for muscular and selected perimembranous VSD anatomies. Flexible device architecture supports adaptation to complex anatomical structures while retrievable deployment systems provide additional procedural control during implantation.

The Cera PDA Occluder devices are engineered with conical geometries optimized for different ductal anatomies. Their low-profile delivery systems provide important advantages, particularly in pediatric interventions.

Advanced delivery systems used throughout the Cera Series support controlled deployment and repositioning capabilities. Operators can retrieve or reposition the device when necessary, improving procedural precision and intervention safety in complex anatomies.

Through minimally invasive transcatheter treatment strategies, the Cera Series offers important advantages compared with open surgical repair procedures, including reduced procedural trauma and shorter recovery periods. As a result, transcatheter structural heart interventions continue to gain broader adoption in contemporary cardiology practice.

In clinical use, the Cera Series is recognized for its enhanced biocompatibility strategy, ceramic coating technology, controlled deployment performance, and broad treatment versatility. The systems are widely considered effective solutions for pediatric cardiology and structural heart intervention procedures.

In summary, the Cera Series represents an advanced family of transcatheter closure systems developed for ASD, VSD, PDA, and PFO treatment applications. Through ceramic coating innovation, enhanced biocompatibility, and versatile clinical applicability, the Cera Series provides a strong solution platform for modern interventional cardiology.